Excipients Group Seeks Seat At GDUFA Negotiating Table
But US FDA Skeptical, As GDUFA III Approaches
Executive Summary
IPEC-Americas requests an improved communications channel with the FDA and formal inclusion in talks to reauthorize the generic drug user fee program; agency says industry negotiators generally represent product manufacturers and API suppliers that are subject to user fees.